Tissue Specificity: Expressed exclusively in the lens, particularly during terminal differentiation of secondary lens fibers .
Post-Translational Modification: Undergoes N-terminal truncation in vivo, resulting in a ~51 kDa fragment .
Recombinant Rat LGSN is used in:
Antibody Blocking: Human LGSN fragments (e.g., aa 98–186) are employed to validate antibody specificity (e.g., PA5-65252) .
ELISA Development: Kits (e.g., Abbexa Ltd) quantify Rat LGSN in serum, plasma, or tissue homogenates .
Functional Studies: Co-immunoprecipitation assays confirm interactions with lens proteins .
Key production parameters are outlined in Table 2.
| Parameter | Details | Source |
|---|---|---|
| Source Organism | Rattus norvegicus | |
| Endotoxin Level | < 1.0 EU/μg (LAL method) | |
| Storage | -20°C to -80°C (lyophilized), +4°C (short-term) | |
| Buffer | PBS buffer |
Mechanistic Studies: Investigating LGSN’s role in lens transparency and cataract pathogenesis.
Therapeutic Potential: Exploring its chaperone activity in protein folding diseases.
Evolutionary Insights: Tracing the transition from enzymatic to structural roles in vertebrates.
Rat Lengsin (Lgsn) is a member of the glutamine synthetase (GS) superfamily that exhibits evidence of dynamic evolutionary history in the vertebrate lens. While it shares structural similarities with prokaryotic class I GS proteins, it has undergone significant modifications throughout evolution. The protein shows considerable variability in sequence and length in the N-terminal regions across vertebrate species, while the remainder of the sequence remains well conserved .
Evolutionary analyses have revealed that Lengsin has experienced gain and loss of exons and major changes in the N-terminal domain length. In zebrafish and chicken, the Lengsin gene has four exons, whereas in mammals like rat, it has five exons. This evolutionary divergence suggests that Lengsin may have been re-engineered from an enzymatic protein to serve a structural or binding role specific to the lens .
Lengsin shows a remarkably restricted expression pattern in the rat lens. Northern blot analyses of multitissue samples demonstrate that Lengsin mRNA is detectable only in the adult lens, not in retina or in newborn lens tissue . Western blot analyses of dissected epithelial and fiber cells show that Lengsin protein (appearing as a doublet of bands at 62 and 51 kDa) is exclusively present in fiber cells, not in epithelial cells .
In situ hybridization studies reveal that Lengsin is expressed in a ring of fiber cells undergoing terminal differentiation and nuclear loss. This highly specific spatiotemporal expression pattern suggests that Lengsin serves as a marker for terminal differentiation in the lens and may play critical roles in secondary fiber cell morphogenesis and organization .
The protein exists in two forms: a full-length 62 kDa form and a truncated 51 kDa species resulting from cleavage at an Asp-Pro sequence near the junction between the N-terminal domain and the remainder of the molecule. This post-translational modification appears to occur both in recombinant protein preparations and in vivo, as detected in lens extracts .
Notable structural differences between Lengsin and bacterial GS include the presence of "pillar" densities on the outer region of the Lengsin dodecamer and differences in the β-hairpin regions that form the central β-sheet collar in GS I dodecamers .
Based on successful expression protocols for recombinant Lengsin and other rat proteins, the following methodology is recommended:
Clone the rat Lengsin coding sequence into a pET expression vector system with an N-terminal His-tag for purification purposes.
Transform the construct into an E. coli expression strain such as BL21(DE3).
Grow transformed bacteria in LB medium supplemented with appropriate antibiotics at 37°C until mid-log phase (OD600 of 0.6-0.8).
Induce protein expression with 0.5-1.0 mM IPTG.
Reduce the temperature to 16-18°C after induction and continue expression overnight to minimize protein aggregation and inclusion body formation.
Harvest cells by centrifugation and proceed with lysis and purification .
Note that while mouse Lengsin expresses as a soluble protein in E. coli, human Lengsin tends to form insoluble aggregates. Rat Lengsin behavior may vary, requiring optimization of expression conditions to maximize solubility .
For efficient purification of rat Lengsin, a multi-step purification process is recommended:
Cell lysis: Resuspend bacterial pellet in lysis buffer (typically 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM DTT, and protease inhibitors). Lyse cells using sonication or pressure-based methods.
Initial purification: Perform immobilized metal affinity chromatography (IMAC) using Ni-NTA resin to capture the His-tagged Lengsin protein. Use a gradient elution with increasing imidazole concentration (up to 250-300 mM).
Secondary purification: Apply the eluted protein to size exclusion chromatography (SEC) to separate the dodecameric Lengsin from aggregates and degradation products.
Quality control: Verify protein purity using SDS-PAGE and Western blotting. Assess the oligomeric state using native PAGE or analytical SEC.
Storage: Store purified Lengsin at -70°C in a buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 10% glycerol to prevent degradation .
Monitor for the appearance of the 51 kDa truncated form during storage, as Lengsin tends to undergo cleavage at the Asp-Pro site near the N-terminal junction .
The N-terminal truncation of rat Lengsin, resulting in a 51 kDa species from the full-length 62 kDa protein, occurs due to non-enzymatic hydrolysis at an Asp-Pro sequence near the junction between the N-terminal domain and the remainder of the sequence . To address this issue:
Prevention strategies:
Add protease inhibitors during all purification steps
Minimize storage time at temperatures above -70°C
Consider site-directed mutagenesis to modify the Asp-Pro site without affecting protein function
Use freshly purified protein for critical experiments
Analytical approaches:
Perform peptide mass fingerprinting to precisely identify the cleavage site
Use N-terminal sequencing to confirm the start of the truncated species
Conduct Western blot analysis using antibodies specific to different regions of Lengsin
Experimental considerations:
A table summarizing identified peptides from N-terminal truncation analysis:
| Peptide | Position |
|---|---|
| (K)VIHGVFMPR | 167–175 |
| (R)VLPWAER | 212–218 |
| (R)YNYIASLVIETGFCNSGILSHSIWDVGGK | 350–378 |
| (K)QALGETFIR | 528–536 |
| (K)YELENEETDAEGNKFLETFI | 544–563 |
Several complementary approaches can be employed to identify and characterize Lengsin's binding partners:
Yeast Two-Hybrid (Y2H) Screening:
Co-immunoprecipitation (Co-IP):
Generate antibodies against rat Lengsin or use epitope-tagged recombinant protein
Prepare lens extracts under conditions that preserve protein-protein interactions
Immunoprecipitate Lengsin complexes and identify binding partners by mass spectrometry
Confirm interactions by reciprocal Co-IP and Western blotting
Pull-down Assays:
Use purified recombinant His-tagged Lengsin as bait
Incubate with lens extracts and capture complexes with Ni-NTA beads
Analyze bound proteins by SDS-PAGE and mass spectrometry
Perform binding assays with purified candidate partners to determine direct interactions
Proximity Labeling:
Previous studies have shown that Lengsin can bind to the 2B filament region of vimentin but not to the equivalent regions of CP49 or filensin, suggesting specificity in its interactions with cytoskeletal components .
To investigate Lengsin's role in lens fiber cell differentiation, researchers can employ the following methodological approaches:
Morpholino-mediated Knockdown (validated in zebrafish):
CRISPR-Cas9 Gene Editing:
Transgenic Overexpression:
Create constructs with Lengsin under control of lens-specific promoters
Generate transgenic rats expressing Lengsin at different stages of lens development
Examine the effects of altered timing or level of Lengsin expression on fiber cell differentiation
Ex Vivo Lens Culture:
Statistical analysis of morphological defects should include measurement of lens size, quantification of tissue separations, and assessment of fiber cell organization patterns. In one zebrafish study, the average total lens separation areas were 257 μm² in controls versus 1,175 μm² in Lengsin morphants, demonstrating a statistically significant difference (p<0.05) .
Despite Lengsin's structural similarity to glutamine synthetase (GS) proteins, extensive enzymatic testing has failed to demonstrate catalytic activity. The following assays have been attempted with recombinant Lengsin:
Glutamine Synthetase Activity:
Alternative Amide Donors:
Protein Deamidation:
ATP Binding:
The lack of enzymatic activity is consistent with sequence analysis showing that critical residues for catalytic activity are not conserved in Lengsin. This suggests that Lengsin may have been evolutionarily repurposed from an enzymatic protein to one with a structural or binding role in the lens, similar to the recruitment of several taxon-specific enzyme crystallins .
When designing experiments involving rat Lengsin, researchers should consider strain-specific variations that may affect expression, structure, or function:
Strain Selection Considerations:
Common laboratory rat strains like Sprague-Dawley, Wistar, and Fischer 344 may exhibit differences in Lengsin expression levels or patterns
Inbred strains offer genetic homogeneity that reduces experimental variability
Outbred strains better represent natural genetic diversity but introduce more variability
Documented Strain Variations:
While specific strain differences in Lengsin have not been thoroughly documented, genetic background can significantly impact lens development and protein expression
For example, the DA and ACI rat strains have been successfully used in embryonic stem cell (ESC) studies and may be suitable for Lengsin research
Experimental Design Recommendations:
Maintain consistent strain usage throughout a study
Report complete strain information in publications
Consider comparing results across multiple strains to assess generalizability
For genetically modified rat models, use appropriate background controls from the same strain
Account for potential sex differences in Lengsin expression or function
Quality Control Measures:
Verify Lengsin expression levels in each strain before beginning experiments
Monitor genetic drift in colony-maintained strains through periodic genotyping
Consider using commercially available rats with defined genetic backgrounds for critical experiments
Researchers working with genetically modified rats should be aware that even with CRISPR-based methods, genetic background needs to be controlled to reduce reproducibility problems associated with mixed undefined genomic backgrounds .
Developing effective antibodies against rat Lengsin presents several challenges that researchers should address with specific strategies:
Challenge: Cross-reactivity with other GS family members
Solution: Design immunizing peptides or recombinant fragments from unique regions of Lengsin, particularly the variable N-terminal domain
Approach: Perform sequence alignment of Lengsin with other GS family members to identify Lengsin-specific epitopes
Challenge: Limited cross-reactivity between species
Solution: For species-specific studies, raise antibodies against the corresponding species' Lengsin
Evidence: Anti-mouse Lengsin antibodies detect mouse, rat, and rabbit Lengsin, but not human or dog Lengsin
Approach: Consider targeting highly conserved regions for cross-species reactivity or variable regions for species specificity
Challenge: Recognizing both full-length and N-terminally truncated forms
Solution: Target epitopes in the conserved C-terminal region present in both forms
Approach: Use the purified recombinant protein containing both 62 and 51 kDa species as immunogen
Challenge: High specificity requirements for immunolocalization
Solution: Purify antibodies using affinity chromatography with immobilized recombinant Lengsin
Approach: Validate antibody specificity using tissues from Lengsin knockout animals as negative controls
Challenge: Conformational epitopes in the native dodecameric structure
Solution: Immunize with properly folded recombinant protein rather than denatured protein or peptides
Approach: Use native protein for immunization and develop conformational epitope-specific antibodies
Recommended protocol for antibody development:
Express and purify soluble recombinant rat Lengsin as described in section 2.2
Immunize rabbits or other suitable hosts with the purified protein
Collect antisera and test reactivity in Western blots of lens extracts
Validate antibody specificity through immunohistochemistry on rat lens sections
If necessary, perform affinity purification using recombinant Lengsin
This approach has successfully generated polyclonal antisera that detect both the 62 and 51 kDa Lengsin species in lens extracts .
The dodecameric structure of rat Lengsin presents analytical challenges that require specialized approaches:
Cryo-Electron Microscopy (Cryo-EM):
Methodology: Prepare purified Lengsin at 0.5-2.0 mg/ml in a buffer suitable for vitrification
Analysis: Perform single-particle reconstruction to achieve high-resolution structural information
Advantage: Allows visualization of the native dodecameric structure without crystallization
Challenge: Requires high-quality, homogeneous protein preparations
Resolution enhancement: Use of direct electron detectors and advanced image processing algorithms can improve resolution
Comparative Structural Analysis:
Methodology: Compare Lengsin structure with bacterial GS structures through rigid body refinement
Key findings: Lengsin has additional "pillar" densities not present in bacterial GS
Sequence analysis: Examine regions like the loop sequence between positions 430-435 (in GS numbering) that may differ between Lengsin and GS
Structure-Function Analysis:
Site-directed mutagenesis: Target residues in regions that differ from bacterial GS
Domain swapping: Create chimeric proteins between Lengsin and bacterial GS to identify functional domains
Truncation analysis: Compare properties of full-length and N-terminally truncated forms
Protein-Protein Interaction Mapping:
Cross-linking mass spectrometry: Identify residues involved in inter-subunit contacts
Hydrogen-deuterium exchange: Map surface accessibility and conformational dynamics
Computational docking: Model interactions with binding partners like vimentin
Stability and Assembly Analysis:
Analytical ultracentrifugation: Determine oligomeric state and assembly kinetics
Differential scanning calorimetry: Assess thermal stability of the dodecameric complex
Native mass spectrometry: Analyze intact complexes and subcomplexes
Image reconstruction has revealed that Lengsin forms a structure with dimensions of 140 Å in diameter and ~100 Å in height, with a calculated molecular weight of 744,372 Da for the full-length dodecamer or 605,952 Da for the N-terminally truncated form .
Recombinant rat Lengsin offers several valuable applications as a marker for terminal differentiation in lens research:
Antibody-based Detection Systems:
Immunohistochemistry: Using anti-Lengsin antibodies to identify terminally differentiating fiber cells in tissue sections
Immunofluorescence: Performing co-localization studies with other differentiation markers
Flow cytometry: Sorting lens cell populations based on Lengsin expression
Western blotting: Quantifying Lengsin expression levels during differentiation processes
Transgenic Reporter Systems:
Lengsin promoter-driven reporters: The 3 kb genomic fragment upstream of Lengsin can drive expression of reporter genes like EGFP specifically in terminally differentiating lens fibers
Applications: Tracking differentiation in vivo, isolating specific cell populations, testing effects of experimental manipulations on differentiation
Validation: Transgenic lines using Lengsin promoter-EGFP constructs recapitulate the temporal and spatial expression patterns of endogenous Lengsin
Developmental Stage Marker:
Timeline reference: Lengsin expression follows the temporal expression of αA-, αB1-, and βB1-crystallin proteins in the lens
Spatial reference: At 72 hpf in zebrafish, Lengsin localizes to a subpopulation of differentiating secondary fiber cells, while no expression is detected in epithelial cells or central lens fibers
Application: Using Lengsin expression to standardize developmental staging across experiments
Quality Control for Differentiation:
In vitro differentiation: Monitoring successful lens fiber differentiation in culture systems
Tissue engineering: Verifying proper terminal differentiation in engineered lens tissues
Stem cell research: Confirming lens lineage commitment in differentiation protocols
For developmental studies, researchers should note that Lengsin expression is first detected in zebrafish at 24 hours post-fertilization (hpf), with protein detectable by immunostaining at 30 hpf. In adult lenses, Lengsin is restricted to a narrow band of cortical fibers and co-localizes with actin at the lateral faces of interdigitating cells .
The demonstrated interaction between Lengsin and vimentin offers significant insights for lens cytoskeletal research:
Mechanistic Implications:
Lengsin binds specifically to the 2B filament region of vimentin but not to equivalent regions in CP49 or filensin, suggesting selective cytoskeletal interactions
This interaction may help organize the cytoskeleton during terminal differentiation of lens fiber cells
The dodecameric structure of Lengsin could potentially cross-link multiple vimentin filaments, contributing to the specialized cytoskeletal architecture of lens fibers
Research Approaches:
In vitro filament assembly: Assess how recombinant Lengsin affects vimentin polymerization and network formation
FRET or BRET analysis: Measure direct interactions in living cells
Super-resolution microscopy: Visualize co-localization patterns at nanoscale resolution
Electron microscopy: Examine ultrastructural relationships between Lengsin and vimentin filaments
Functional Studies:
Compare cytoskeletal organization in normal and Lengsin-deficient lenses
Examine whether Lengsin-vimentin interactions are regulated by post-translational modifications
Investigate if the N-terminal truncation of Lengsin affects its interaction with vimentin
Determine whether Lengsin-vimentin interactions change during lens aging or cataract formation
Experimental Design Considerations:
Use both full-length and N-terminally truncated Lengsin in binding studies
Consider species differences in vimentin sequence when designing experiments
Account for potential regulatory factors in the cellular environment that may modify interactions
Develop methods to quantify binding affinities and kinetics under physiological conditions
This interaction may explain the observed morphological defects in Lengsin knockdown models, where disruption of proper cytoskeletal organization could lead to the observed separations within the lens cortex and defects in secondary fiber morphogenesis .
Integrating Lengsin research with studies of other lens-specific proteins requires a comprehensive, multi-layered approach:
Coordinated Expression Analysis:
Temporal profiling: Compare expression timelines of Lengsin with crystallins, intermediate filament proteins, and other lens-specific factors during development
Spatial mapping: Determine precise localization patterns of multiple proteins within the lens using multiplexed immunostaining or in situ hybridization
Single-cell transcriptomics: Profile gene expression at single-cell resolution to identify co-regulated gene clusters during differentiation
Protein Interaction Networks:
Interactome mapping: Perform systematic protein-protein interaction screens to identify links between Lengsin and other lens proteins
Co-immunoprecipitation studies: Isolate multi-protein complexes containing Lengsin from lens tissue
Proximity labeling: Use BioID or APEX2 fusions to identify proteins in close proximity to Lengsin in vivo
Network analysis: Construct interaction maps to identify key hubs and regulatory connections
Functional Genomics Approaches:
Combinatorial knockdowns/knockouts: Assess synergistic effects of modulating Lengsin together with other lens proteins
Transgenic models: Create rats expressing reporters for multiple lens proteins to track differentiation dynamics
CRISPR screens: Perform genome-wide or targeted screens to identify factors affecting Lengsin expression or function
Integrative Analysis Tools:
Pathway analysis: Identify signaling pathways connecting Lengsin with other differentiation factors
Gene Ontology enrichment: Categorize functional relationships among co-expressed genes
Proteomics data integration: Combine protein expression, modification, and interaction data
Comparative genomics: Examine evolutionary conservation of lens differentiation programs
Experimental Systems:
Lens-specific promoters: The γD-crystallin promoter contains activating sequences active in lens cells and silencing sequences active in non-lens cells that could be used in conjunction with Lengsin regulatory elements
Transgenic resources: The Lengsin promoter (3 kb upstream fragment) has been validated to drive lens-specific expression and can be used to create multi-reporter systems
Differentiation models: Compare Lengsin with factors like FGF2, which promotes retinal lens fiber differentiation through ERK1/2 phosphorylation
For example, researchers could create a transgenic rat model with Lengsin promoter driving one fluorescent reporter and crystallin promoters driving different colored reporters to visualize the progression of differentiation in real-time and in fixed tissue samples.